Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Glycosides | 2 | 2015 | 2 | 0.900 |
Why?
|
| Trophoblasts | 2 | 2015 | 114 | 0.810 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 196 | 0.490 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 124 | 0.440 |
Why?
|
| Imidazoles | 1 | 2015 | 219 | 0.410 |
Why?
|
| Pyridines | 1 | 2015 | 258 | 0.410 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 141 | 0.390 |
Why?
|
| Bufanolides | 2 | 2024 | 13 | 0.320 |
Why?
|
| Cell Proliferation | 2 | 2024 | 2463 | 0.290 |
Why?
|
| Anesthesia, Obstetrical | 2 | 2025 | 38 | 0.270 |
Why?
|
| Gynecology | 2 | 2019 | 128 | 0.270 |
Why?
|
| Obstetrics | 2 | 2019 | 239 | 0.240 |
Why?
|
| Sterilization, Tubal | 1 | 2025 | 13 | 0.230 |
Why?
|
| Anesthesia, Spinal | 1 | 2025 | 13 | 0.230 |
Why?
|
| Anesthesia, Epidural | 1 | 2025 | 19 | 0.220 |
Why?
|
| Substance Abuse Detection | 1 | 2024 | 39 | 0.220 |
Why?
|
| Apoptosis | 2 | 2024 | 1832 | 0.210 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2025 | 221 | 0.190 |
Why?
|
| Pre-Eclampsia | 1 | 2024 | 225 | 0.180 |
Why?
|
| Pregnancy | 8 | 2025 | 7405 | 0.180 |
Why?
|
| Cesarean Section | 1 | 2025 | 422 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2024 | 520 | 0.170 |
Why?
|
| Career Choice | 2 | 2019 | 167 | 0.160 |
Why?
|
| Education | 1 | 2019 | 112 | 0.150 |
Why?
|
| Internship and Residency | 2 | 2019 | 1217 | 0.140 |
Why?
|
| Students, Medical | 2 | 2019 | 352 | 0.130 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2018 | 80 | 0.120 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 503 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2020 | 801 | 0.110 |
Why?
|
| Ouabain | 1 | 2014 | 17 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2018 | 435 | 0.100 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 115 | 0.100 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2014 | 39 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 707 | 0.100 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 104 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 258 | 0.100 |
Why?
|
| Brain | 1 | 2024 | 3169 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2019 | 1059 | 0.090 |
Why?
|
| Cell Line | 1 | 2015 | 2557 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 1001 | 0.080 |
Why?
|
| Stroke | 1 | 2018 | 1060 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2895 | 0.070 |
Why?
|
| Female | 8 | 2025 | 70465 | 0.070 |
Why?
|
| Humans | 10 | 2025 | 130600 | 0.060 |
Why?
|
| Adult | 5 | 2025 | 31169 | 0.050 |
Why?
|
| Capillary Permeability | 1 | 2024 | 73 | 0.050 |
Why?
|
| Heart Failure | 1 | 2018 | 2331 | 0.050 |
Why?
|
| Microvessels | 1 | 2024 | 58 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2025 | 143 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2024 | 153 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2025 | 238 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2025 | 349 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 302 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2025 | 5049 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2024 | 1571 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17569 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 122 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2024 | 542 | 0.040 |
Why?
|
| Seizures | 1 | 2024 | 874 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 514 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 4043 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 6223 | 0.040 |
Why?
|
| Anxiety | 1 | 2025 | 1006 | 0.030 |
Why?
|
| Florida | 1 | 2018 | 72 | 0.030 |
Why?
|
| Forecasting | 1 | 2018 | 350 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 725 | 0.030 |
Why?
|
| Motivation | 1 | 2018 | 327 | 0.030 |
Why?
|
| Texas | 1 | 2024 | 3648 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2020 | 602 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6440 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2024 | 4668 | 0.020 |
Why?
|
| Male | 1 | 2018 | 64575 | 0.010 |
Why?
|